Hamilton Bennett | Sr. Director Vaccine Access and Partnerships
Moderna

Hamilton Bennett (she/her) is the Senior Director of Vaccine Access and Partnerships at Moderna, a company pioneering messenger RNA (mRNA) therapeutics and vaccines. Hamilton maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. In this role, Hamilton led the mRNA-1273 COVID-19 vaccine development Program Team to the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic. Most recently, Hamilton launched mRNA Access to provide researchers access to Moderna’s early development engine to collaboratively advance novel vaccines targeting emerging and neglected infectious disease. Prior to Moderna, Hamilton led small molecule and monoclonal antibody pandemic preparedness programs at two Boston biotech companies. Hamilton holds a M.Sc from University of Washington in Environmental Health with a focus on Global Health, and a B.Sc from McGill University in Agricultural Chemistry and is pursuing an executive MBA from MIT.